Literature DB >> 10722598

Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response.

S Mattoo1, J F Miller, P A Cotter.   

Abstract

Fimbriae are filamentous, cell surface structures which have been proposed to mediate attachment of Bordetella species to respiratory epithelium. Bordetella bronchiseptica has four known fimbrial genes: fim2, fim3, fimX, and fimA. While these genes are unlinked on the chromosome, their protein products are assembled and secreted by a single apparatus encoded by the fimBCD locus. The fimBCD locus is embedded within the fha operon, whose genes encode another putative adhesin, filamentous hemagglutinin (FHA). We have constructed a Fim(-) B. bronchiseptica strain, RB63, by introducing an in-frame deletion extending from fimB through fimD. Western blot analysis showed that RB63 is unable to synthesize fimbriae but is unaffected for FHA expression. Using this mutant, we assessed the role of fimbriae in pathogenesis in vitro and in vivo in natural animal hosts. Although RB63 was not significantly defective in its ability to adhere to various tissue culture cell lines, including human laryngeal HEp-2 cells, it was considerably altered in its ability to cause respiratory tract infections in rats. The number of DeltafimBCD bacteria recovered from the rat trachea at 10 days postinoculation was significantly decreased compared to that of wild-type B. bronchiseptica and was below the limit of detection at 30 and 60 days postinoculation. The number of bacteria recovered from the nasal cavity and larynx was not significantly different between RB63 and the wild-type strain at any time point. The ability of fimbriae to mediate initial attachment to tracheal tissue was tested in an intratracheal inoculation assay. Significantly fewer RB63 than wild-type bacteria were recovered from the tracheas at 24 h after intratracheal inoculation. These results demonstrate that fimbriae are involved in enhancing the ability of B. bronchiseptica to establish tracheal colonization and are essential for persistent colonization at this site. Interestingly, anti-Bordetella serum immunoglobulin M (IgM) levels were significantly lower in animals infected with RB63 than in animals infected with wild-type B. bronchiseptica at 10 days postinoculation. Even at 30 days postinoculation, RB63-infected animals had lower serum anti-Bordetella antibody titers in general. This disparity in antibody profiles suggests that fimbriae are also important for the induction of a humoral immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722598      PMCID: PMC97382          DOI: 10.1128/IAI.68.4.2024-2033.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Cloning of a novel pilin-like gene from Bordetella pertussis: homology to the fim2 gene.

Authors:  P Pedroni; B Riboli; F de Ferra; G Grandi; S Toma; B Aricò; R Rappuoli
Journal:  Mol Microbiol       Date:  1988-07       Impact factor: 3.501

Review 3.  Virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett
Journal:  Annu Rev Microbiol       Date:  1986       Impact factor: 15.500

Review 4.  The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp.

Authors:  C Locht; P Bertin; F D Menozzi; G Renauld
Journal:  Mol Microbiol       Date:  1993-08       Impact factor: 3.501

5.  Experimental pertussis infection in the rabbit: similarities with infection in primates.

Authors:  N W Preston; R M Timewell; E J Carter
Journal:  J Infect       Date:  1980-09       Impact factor: 6.072

6.  Newborn rabbit alveolar macrophages are deficient in two microbicidal cationic peptides, MCP-1 and MCP-2.

Authors:  T Ganz; M P Sherman; M E Selsted; R I Lehrer
Journal:  Am Rev Respir Dis       Date:  1985-10

7.  An nptI-sacB-sacR cartridge for constructing directed, unmarked mutations in gram-negative bacteria by marker exchange-eviction mutagenesis.

Authors:  J L Ried; A Collmer
Journal:  Gene       Date:  1987       Impact factor: 3.688

8.  Experimental infection of Bordetella bronchiseptica to rabbits.

Authors:  H Yoda; K Nakayama; M Nakagawa
Journal:  Jikken Dobutsu       Date:  1982-04

9.  Genetic diversity and relationships in populations of Bordetella spp.

Authors:  J M Musser; E L Hewlett; M S Peppler; R K Selander
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

10.  Genetic analysis of a region of the Bordetella pertussis chromosome encoding filamentous hemagglutinin and the pleiotropic regulatory locus vir.

Authors:  S Stibitz; A A Weiss; S Falkow
Journal:  J Bacteriol       Date:  1988-07       Impact factor: 3.490

View more
  44 in total

1.  Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.

Authors:  Michael W Henderson; Carol S Inatsuka; Amanda J Sheets; Corinne L Williams; David J Benaron; Gina M Donato; Mary C Gray; Erik L Hewlett; Peggy A Cotter
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

2.  Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.

Authors:  Neelima Sukumar; Gina Parise Sloan; Matt S Conover; Cheraton F Love; Seema Mattoo; Nancy D Kock; Rajendar Deora
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

3.  Bordetella bronchiseptica adherence to cilia is mediated by multiple adhesin factors and blocked by surfactant protein A.

Authors:  Jessica A Edwards; Nathan A Groathouse; Scott Boitano
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung.

Authors:  Daniel P Widney; Yan Hu; Amy K Foreman-Wykert; Kim C Bui; Tam T Nguyen; Bao Lu; Craig Gerard; Jeff F Miller; Jeffrey B Smith
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation.

Authors:  Annette Reissinger; Jason A Skinner; Ming H Yuk
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica.

Authors:  Tracy L Nicholson; Anne M Buboltz; Eric T Harvill; Susan L Brockmeier
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

7.  The prodomain of the Bordetella two-partner secretion pathway protein FhaB remains intracellular yet affects the conformation of the mature C-terminal domain.

Authors:  Christopher R Noël; Joseph Mazar; Jeffrey A Melvin; Jessica A Sexton; Peggy A Cotter
Journal:  Mol Microbiol       Date:  2012-10-05       Impact factor: 3.501

8.  Contribution of Bordetella bronchiseptica filamentous hemagglutinin and pertactin to respiratory disease in swine.

Authors:  Tracy L Nicholson; Susan L Brockmeier; Crystal L Loving
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

9.  Respiratory disease in kennelled dogs: serological responses to Bordetella bronchiseptica lipopolysaccharide do not correlate with bacterial isolation or clinical respiratory symptoms.

Authors:  Victoria J Chalker; Crista Toomey; Shaun Opperman; Harriet W Brooks; Michael A Ibuoye; Joe Brownlie; Andrew N Rycroft
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

10.  Genomic and genetic analysis of Bordetella bacteriophages encoding reverse transcriptase-mediated tropism-switching cassettes.

Authors:  Minghsun Liu; Mari Gingery; Sergei R Doulatov; Yichin Liu; Asher Hodes; Stephen Baker; Paul Davis; Mark Simmonds; Carol Churcher; Karen Mungall; Michael A Quail; Andrew Preston; Eric T Harvill; Duncan J Maskell; Frederick A Eiserling; Julian Parkhill; Jeff F Miller
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.